NCT06350500

Brief Summary

This clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve patient knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance patient skills related to management of cancer treatment. Offering a patient navigation program may increase health equity and improve social needs and quality of life over time for newly diagnosed breast cancer patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
23mo left

Started Dec 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Dec 2024Mar 2028

First Submitted

Initial submission to the registry

April 1, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 5, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

December 15, 2024

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2028

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

3.2 years

First QC Date

April 1, 2024

Last Update Submit

February 11, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Enrollment rate

    Enrollment rate Will be defined as the number of patients enrolled divided by the number of patients approached. The enrollment rate will be estimated with a 90% credible region obtained by Jeffrey's prior method.

    Up to 2 years

  • Reasons for refusal

    Reported reasons of refusal will be summarized using frequencies and relative frequencies

    Up to 2 years

  • Retention Rate

    The number of patients that complete patient navigation divided by the number of patients enrolled

    Up to 2 years

  • Reasons for discontinuation

    Will be summarized using frequencies and relative frequencies

    Up to 2 years

Secondary Outcomes (5)

  • European Organization for Research and Treatment of Cancer Quality of Life Scale (EORTC QLQ-C30)

    Up to 2 years

  • Social Determinates of health

    Up to 2 years

  • Barriers to care

    Up to 2 years

  • Use of supportive services

    Up to 2 years

  • Patient Satisfaction survey

    up to 2 years

Study Arms (1)

Health Services Research (Patient Navigation)

EXPERIMENTAL

Patients receive patient navigation services from a patient navigator as needed to improve knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance skills related to management of cancer treatment

Behavioral: Patient NavigationOther: Questionnaire

Interventions

Receive patient navigation

Health Services Research (Patient Navigation)

Ancillary studies

Health Services Research (Patient Navigation)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years of age
  • Have a confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS)
  • Currently identify their gender as woman or female
  • Was assigned female sex at birth (AFAB)
  • \- Participant is experiencing ≥1 barrier to care as determined by the social needs screening tool
  • Participant must understand the investigational nature of this study and verbally consent to participate prior to receiving any study related intervention

You may not qualify if:

  • Participants who are not suspected of or diagnosed with breast cancer or Ductal Carcinoma in Situ (DCIS)
  • Participants who have had a previous diagnosis of any cancer
  • Participants who were assigned male sex or intersex at birth
  • Unwilling or unable to follow protocol requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roswell Park Comprehensive Cancer Center

Buffalo, New York, 14263, United States

RECRUITING

MeSH Terms

Conditions

Breast NeoplasmsCarcinoma, Intraductal, Noninfiltrating

Interventions

Patient NavigationSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeBreast Carcinoma In SituCarcinoma in SituNeoplasms, Ductal, Lobular, and Medullary

Intervention Hierarchy (Ancestors)

Patient-Centered CarePrimary Health CareComprehensive Health CarePatient Care ManagementHealth Services AdministrationData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Kathryn Glaser

    Roswell Park Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2024

First Posted

April 5, 2024

Study Start

December 15, 2024

Primary Completion (Estimated)

March 15, 2028

Study Completion (Estimated)

March 15, 2028

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations